Craneware Shares Retreat After Initial Gains Despite Strong Interim Results

Craneware (CRW.L), a healthcare financial performance solutions leader, initially saw its shares open higher today following the release of its FY26 interim results, but the stock has since reversed course, currently trading down approximately 1.9%.

The dip comes despite the company reporting double-digit growth in adjusted EBITDA and EPS, along with a confident outlook fueled by accelerated innovation.

The company announced revenue of $105.7 million for the first half of FY26, a 6% increase compared to $100.0 million in H1 FY25. Adjusted EBITDA rose by 10% to $33.4 million, up from $30.3 million, while adjusted profit before tax climbed 14% to $23.5 million. Adjusted basic EPS also saw a healthy increase of 16%, reaching 58.7 cents compared to 50.6 cents in the prior year.

Craneware's Annual Recurring Revenue (ARR) reached $184.2 million, a 4% increase year-over-year. The company's balance sheet remains strong, with total cash and cash equivalents at $71.2 million, and total bank debt significantly reduced by 26% to $23.4 million. An interim dividend of 15.0 pence per share was declared, an 11% increase from the previous year.

Key Drivers of Craneware's Performance:

• New Customer Acquisition: Sales to new customers increased significantly, representing 12% of total sales in H1 FY26, compared to just 2% in the prior year. This reflects a higher competitive “take-out” rate and provides future expansion opportunities.
• Cross-Selling Success: Craneware continues to expand within existing hospital systems, evidenced by a healthy Net Revenue Retention (NRR) rate of 103% on a 12-month rolling basis.
• Innovation through AI: Investments in data and a partnership with Microsoft are driving accelerated innovation, with new Trisus® functionality set to launch in the second half of the year.

The company's strong cash position and reduced debt have enabled the board to announce a share buyback program of $25 million, further details of which will be released in due course. This move signals confidence in Craneware's financial health and future prospects, but the markets may be indicating that the buyback needs to be executed.

CEO Keith Neilson commented, “High levels of expansion sales, healthy NRR and an increasing 340B Shelter opportunity underpin our confidence in a positive second half performance… These unique strengths underpin future revenue growth acceleration and sustainable, long-term value generation.”